PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
Clinical trials for PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled powder for lung blood pressure condition tested in 80 patients
Disease control Recruiting nowThis study is testing the safety of an inhaled dry powder form of treprostinil (LIQ861) for people with pulmonary hypertension (high blood pressure in the lungs) due to lung disease. About 80 adults will take the drug using a special inhaler, and researchers will monitor for side…
Matched conditions: PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Lifeline for lung patients: TPIP access extended
Disease control AVAILABLEThis study offers continued access to the inhaled drug TPIP for people with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (PH-ILD) who have already completed a related study. Participants must have successfully finished prior …
Matched conditions: PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill hopes to ease breathing in rare lung conditions
Disease control Recruiting nowThis study tests an experimental oral drug called ROC-101 in 40 adults with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (ILD-PH). Participants take the drug alongside their standard care for 24 weeks, with a long-term follow…
Matched conditions: PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: AllRock Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New inhaled drug aims to help lung patients breathe and move easier
Disease control Recruiting nowThis phase 3 trial tests an inhaled drug called treprostinil palmitil in 344 adults with pulmonary hypertension caused by interstitial lung disease. Participants take the drug or a placebo once daily for 24 weeks. The main goal is to see if the drug helps them walk farther in six…
Matched conditions: PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New drug APL-9796 tested for lung blood pressure disorder
Disease control Recruiting nowThis Phase 2 trial tests an experimental drug called APL-9796 in 48 adults with pulmonary hypertension (high blood pressure in the lungs). The study aims to see if the drug is safe, tolerable, and effective. Participants receive injections under the skin, and researchers monitor …
Matched conditions: PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New combo therapy for lung scarring and high blood pressure under study
Disease control Recruiting nowThis study tests a new inhaled drug, mosliciguat, added to an existing treatment (treprostinil) for people with high blood pressure in the lungs caused by lung scarring. The goal is to see if the combination is safe and tolerable. About 20 adults with this condition will particip…
Matched conditions: PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Home workouts could ease breathing in rare lung condition
Symptom relief Recruiting nowThis study tests whether a 16-week home exercise program can improve daily function in 30 adults with pulmonary hypertension linked to interstitial lung disease. Participants will receive daily texts or emails with aerobic and strength exercises. Researchers will measure changes …
Matched conditions: PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
Phase: NA • Sponsor: University of Rochester • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC